Barclays Maintains Underweight on Clorox, Raises Price Target to $139
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Lauren Lieberman maintains an Underweight rating on Clorox (NYSE:CLX) but raises the price target from $137 to $139.
November 01, 2024 | 1:55 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays maintains an Underweight rating on Clorox but slightly raises the price target from $137 to $139, indicating a cautious outlook with a minor positive adjustment.
The Underweight rating suggests a cautious stance on Clorox's stock, indicating that the analyst expects it to underperform relative to the market. However, the slight increase in the price target from $137 to $139 suggests a minor positive adjustment in expectations. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100